Piperidinyl derivatives as modulators of chemokine receptor activity
申请人:Bristol-Myers Squibb Company
公开号:US07985861B2
公开(公告)日:2011-07-26
The present application describes substituted piperidinyl modulators of MIP-1α or CCR-1 or stereoisomers or pharmaceutically acceptable salts thereof. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and transplant rejection using said modulators are disclosed.
[EN] PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY<br/>[FR] DERIVES DE PIPERIDINYL EN TANT QUE MODULATEURS DE L'ACTIVITE DU RECEPTEUR DE CHIMIOKINE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2007092681A2
公开(公告)日:2007-08-16
[EN] The present application describes substituted piperidinyl modulators of MIP-1 or CCR-1 or stereoisomers or pharmaceutically acceptable salts thereof. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and transplant rejection using said modulators are disclosed. [FR] La présente invention concerne des modulateurs de pipéridinyl substitués de MIP-1 ou de CCR-1 ou des stéréoisomères ou sels dérivés pharmaceutiquement acceptables. Sont en outre révélés des procédés de traitement et de prévention de maladies inflammatoires telles que l'asthme et des maladies allergiques, ainsi que des pathologies autoimmunitaires telles que l'arthrite rhumatoïde et le rejet de transplant en utilisant lesdits modulateurs.